Experts in subcutaneous drug delivery systems for self-administration, Haselmeier provides innovative and award-winning individual system solutions to support patients for a successful therapy. This family-owned business covers all steps – from design to planning to industrialization – in the creation of high-quality self-injection systems. In 2020, this well-established company will be able to look back on a 100-year-old success story.
As a leading solutions provider in customized smart drug injection systems, we support reliable, successful therapies. As a leading solution provider for subcutaneous self-injection devices, Haselmeier constantly drives innovation. We develop advanced technology that improves therapy and examine the requirements of therapy efficiency to evolve technology even further. We place patient comfort and the needs of our customers at the heart of our approach.
We believe that while technology can enhance therapy efficiency, the needs of therapy inspire even better solutions. As a proactive partner, we offer high-tech products and bespoke services, and adapt quickly to evolving engineering opportunities or market changes. Our approach is built on a century of experience – and an open, curious mind.
Haselmeier works with pharmaceutical and biotechnology companies to improve the lives of patients by manufacturing pens and auto-injectors that are convenient, reliable and that can be dosed with precision.
Spread across seven global locations on three different continents, the Haselmeier Group employs a workforce of more than 240 people. Our development and operations facility is located in Stuttgart, Germany with global manufacturing facilities in Germany, Czech Republic and India. Our manufacturing capabilities include high volume injection molding, precision machining, manual and fully automated pen assembly.
As a full-service provider, Haselmeier can support you with a lot more than just R&D, product development and pen assembly. We also provide certified pharmaceutical manufacturing services, and so are able to offer pharmaceutical and biotechnological companies a comprehensive assembly, labeling and packaging service. As a result, we are able to support these companies with their drug manufacturing challenges.
Our innovative reusable and disposable product platforms, connected devices, data management and related service portfolios assist you every step of the way – leading to an advanced combination of drug and device that is as time-saving and economical for your company as it is safe and convenient in therapy. We support you at every stage – from technology to therapy.
Rapid drug development, smooth conduct of clinical trials and fast time-to-market are high priorities for pharmaceuticals companies. For drugs designed for subcutaneous application, self-injection pens from Haselmeier can help reduce risk and shorten time-to-market.
Posted Date: 11/25/2019
This record has been viewed 424 times.